{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:20:26Z","timestamp":1778401226667,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.802584\/2023-00"],"award-info":[{"award-number":["88887.802584\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-21712-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:39:37Z","timestamp":1743755977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Covid-19 pandemic on azithromycin, chloroquine\/hydroxychloroquine and ivermectin outpatient consumption in Brazil: a joinpoint regression analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Michele Costa","family":"Caetano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Cristina Martins","family":"Emmerick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica Rodrigues","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Castanehira","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika J.","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia","family":"Luiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"10229","key":"21712_CR1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"21712_CR2","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","volume":"178","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787.","journal-title":"Antiviral Res"},{"issue":"2","key":"21712_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375.","journal-title":"J Infect"},{"key":"21712_CR4","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.lana.2021.100089","volume":"4","author":"L Furlan","year":"2021","unstructured":"Furlan L, Caramelli B. The regrettable story of the Covid Kit and the early treatment of Covid-19 in Brazil. Lancet Reg Health - Americas. 2021;4:100089.","journal-title":"Lancet Reg Health - Americas"},{"key":"21712_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/0034-761220200556","volume":"55","author":"G Casar\u00f5es","year":"2021","unstructured":"Casar\u00f5es G, Magalh\u00e3es D. The hydroxychloroquine alliance: how far-right leaders and alt-science preachers came together to promote a miracle drug. Rev Adm P\u00fablica. 2021;55:197\u2013214.","journal-title":"Rev Adm P\u00fablica"},{"issue":"11","key":"21712_CR6","doi-asserted-by":"crossref","first-page":"e20044","DOI":"10.2196\/20044","volume":"22","author":"K Niburski","year":"2020","unstructured":"Niburski K, Niburski O. Impact of Trump\u2019s Promotion of Unproven COVID-19 treatments on Social Media and subsequent internet trends: Observational Study. J Med Internet Res. 2020;22(11):e20044.","journal-title":"J Med Internet Res"},{"key":"21712_CR7","unstructured":"Ventura D, de FL, Reis RR. An unprecedented attack on human rights in Brazil: the timeline of the federal government\u2019s strategy to spread Covid-19. Offprint. Translation by Luis Misiara, revision by Jameson Martins. Bulletin Rights in the Pandemic n. 10. S\u00e3o Paulo, Brazil: CEPEDISA\/USP and Conectas Human Rights; 2021."},{"key":"21712_CR8","first-page":"100322","volume":"14","author":"V Stanford","year":"2022","unstructured":"Stanford V, Gresh L, Toledo J, M\u00e9ndez J, Aldighieri S, Reveiz L. Evidence in decision-making in the context of COVID-19 in Latin America. Lancet Reg Health Am. 2022;14:100322.","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"21712_CR9","doi-asserted-by":"crossref","first-page":"e010962","DOI":"10.1136\/bmjgh-2022-010962","volume":"8","author":"JA Requejo Dom\u00ednguez","year":"2023","unstructured":"Requejo Dom\u00ednguez JA, Mino-Le\u00f3n D, Wirtz VJ. Quality of clinical evidence and political justifications of ivermectin mass distribution of COVID-19 kits in eight latin American countries. BMJ Glob Health. 2023;8(5):e010962.","journal-title":"BMJ Glob Health"},{"key":"21712_CR10","first-page":"e230026","volume":"26","author":"NBLD Silva","year":"2023","unstructured":"Silva NBLD, Rocha RPDS, Andrade ACDS, Ter\u00e7as-Trettel ACP, Muraro AP. Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study. Rev bras Epidemiol. 2023;26:e230026.","journal-title":"Rev bras Epidemiol"},{"key":"21712_CR11","unstructured":"Shalders A. Tratamento precoce\u2019: governo bolsonaro gasta quase R$ 90 milh\u00f5es em rem\u00e9dios ineficazes, mas ainda n\u00e3o pagou butantan por vacinas. BBC NEWS Brasil. 2021. file:\/\/\/C:\/Users\/Michele\/Zotero\/storage\/65AMKR2X\/brasil-55747043.html. Accessed July 2023."},{"key":"21712_CR12","unstructured":"Federal Council of Medicine (CFM). CFM Consultation Process No. 8\/2020. CFM Opinion No. 4\/2020. CFM. 2020. https:\/\/cremers.org.br\/wp-content\/uploads\/2020\/06\/16.04.2020-Parecer-CFM-4-2020-Tratamento-de-Pacientes-Portadores-de-Covid-19-com-Cloroquina-e-Hidroxicloroquina.pdf. Accessed July 2023."},{"key":"21712_CR13","unstructured":"Brazil. Ministry of Health. Executive Secretary. Informative Note No 9\/2020-Se\/Gab\/Se\/Ms. Orienta\u00e7\u00f5es para Manuseio Medicamentoso Precoce de Pacientes com Diagn\u00f3stico da Covid-19. 2022. https:\/\/static.poder360.com.br\/2021\/05\/Nota-informativa-Orienta-es-para-manuseio-medicamentoso-precoce-de-pacientes-com-diagn-stico-da-COVID-19.pdf. Accessed December 2023."},{"key":"21712_CR14","unstructured":"Evans PBRAZIL. An Unfolding Tragedy. Center for Latin American & Caribbean Studies. 2018. https:\/\/clacs.berkeley.edu\/brazil-unfolding-tragedy. Accessed October 2024."},{"key":"21712_CR15","doi-asserted-by":"crossref","unstructured":"Ricard J, Medeiros J. Using misinformation as a political weapon: COVID-19 and Bolsonaro in Brazil. HKS Misinfo Review. 2020. https:\/\/misinforeview.hks.harvard.edu\/article\/using-misinformation-as-a-political-weapon-covid-19-and-bolsonaro-in-brazil\/. Accessed October 2024.","DOI":"10.37016\/mr-2020-013"},{"key":"21712_CR16","doi-asserted-by":"crossref","first-page":"oqad004","DOI":"10.1093\/oodh\/oqad004","volume":"1","author":"C Pagliari","year":"2023","unstructured":"Pagliari C, Klafke GF, Camelo AP, Da Silveira VD, Evans J. The Covid-19 app that lasted two weeks: how technology may embody controversial public policies for health care and why we should worry about it. Oxf Open Digit Health. 2023;1:oqad004.","journal-title":"Oxf Open Digit Health"},{"key":"21712_CR17","unstructured":"Oswaldo Cruz Foundation (Fiocruz). Institute of Communication and Scientific Information Technology in Health. MonitoraCovid-19. 2023. https:\/\/bigdata-covid19.icict.fiocruz.br\/. Accessed December 2023."},{"key":"21712_CR18","unstructured":"Brazil. Ministry of Health. Decree No. 271, February 27, 2013. http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2013\/prt0271_27_02_2013.html. Accessed June 2023."},{"key":"21712_CR19","unstructured":"Brazil, Ministry of Health. Secretariat of Science, Technology, Innovation, and Strategic Health Inputs. Department of Pharmaceutical Assistance and Strategic Inputs. Bnafar Base Nacional de Dados de A\u00e7\u00f5es e Servi\u00e7os da Assist\u00eancia Farmac\u00eautica do Sistema \u00danico de Sa\u00fade: manual do usu\u00e1rio. Bras\u00edlia: Ministry of Health; 2021. http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/base_dados_assistencia_farmaceutica_manual.pdf. Accessed February 2023."},{"key":"21712_CR20","unstructured":"Brazil. Ministry of Health. Decree No. 1.737, June 14, 2018. 2018. https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2018\/prt1737_18_06_2018.html. Accessed January 2024."},{"key":"21712_CR21","unstructured":"Brazil. Ministry of Health. Qualifar-SUS. gov.br: Servi\u00e7os e informa\u00e7\u00f5es do Brasil. 2023 https:\/\/www.gov.br\/saude\/pt-br\/composicao\/sectics\/daf\/cbaf\/qualifar-sus\/qualifar-sus. Accessed January 2024."},{"key":"21712_CR22","unstructured":"Brazil. Ministry of Health. Programa Nacional de Melhoria do Acesso e da Qualidade da Aten\u00e7\u00e3o B\u00e1sica (PMAQ). Ministry of Health. 2017 https:\/\/www.gov.br\/saude\/pt-br\/composicao\/saps\/pmaq\/pmaq. Accessed March 2024."},{"key":"21712_CR23","unstructured":"World Health Organization. GLASS methodology for surveillance of national antimicrobial consumption. Geneva: WHO. 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/336215. Accessed February 2024."},{"key":"21712_CR24","unstructured":"Brazil. Ministry of Health. Datasus. Painel Coronav\u00edrus. Coronav\u00edrus Brasil. 2023. https:\/\/covid.saude.gov.br\/. Accessed December 2023."},{"issue":"2","key":"21712_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijc.23911","volume":"124","author":"D Qiu","year":"2009","unstructured":"Qiu D, Katanoda K, Marugame T, Sobue T. A joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958\u20132004). Int J Cancer. 2009;124(2):443\u20138.","journal-title":"Int J Cancer"},{"issue":"2","key":"21712_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.respe.2010.11.002","volume":"59","author":"M Colonna","year":"2011","unstructured":"Colonna M. Analyse descriptive de la tendance \u00e9volutive d\u2019observations \u00e9pid\u00e9miologiques avec le logiciel Joinpoint: un outil simple, en apparence. Rev \u00c9pid\u00e9miol Sant\u00e9 Publique. 2011;59(2):123\u201333.","journal-title":"Rev \u00c9pid\u00e9miol Sant\u00e9 Publique"},{"key":"21712_CR27","unstructured":"Box GEP, Jenkins GM, Reinsel GC, Ljung GM. Time series analysis: forecasting and control. Fifth edition. Hoboken, New Jersey: Wiley; 1976."},{"issue":"12","key":"21712_CR28","doi-asserted-by":"crossref","first-page":"e1003501","DOI":"10.1371\/journal.pmed.1003501","volume":"17","author":"MS Kim","year":"2020","unstructured":"Kim MS, An MH, Kim WJ, Hwang TH. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. PLoS Med. 2020;17(12):e1003501.","journal-title":"PLoS Med"},{"issue":"4","key":"21712_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4046\/trd.2021.0075","volume":"84","author":"G Mangkuliguna","year":"2021","unstructured":"Mangkuliguna G, Glenardi, Natalia PLA. Efficacy and safety of azithromycin for the treatment of COVID-19: a systematic review and Meta-analysis. Tuberc Respir Dis (Seoul). 2021;84(4):299\u2013316.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"9","key":"21712_CR30","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1007\/s11606-020-05938-4","volume":"35","author":"JJ Harrigan","year":"2020","unstructured":"Harrigan JJ, Hubbard RA, Thomas S, Riello RJ, Bange E, Mamtani M, et al. Association between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing. J Gen Intern Med. 2020;35(9):2826\u20138.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"21712_CR31","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s11606-021-06948-6","volume":"36","author":"JN Lind","year":"2021","unstructured":"Lind JN, Lovegrove MC, Geller AI, Uyeki TM, Datta SD, Budnitz DS. Increase in Outpatient Ivermectin dispensing in the US during the COVID-19 pandemic: a cross-sectional analysis. J Gen Intern Med. 2021;36(9):2909\u201311.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"21712_CR32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/dech.12578","volume":"51","author":"J Putzel","year":"2020","unstructured":"Putzel J. The populist right challenge to neoliberalism: social policy between a rock and a hard place. Dev Change. 2020;51(2):418\u201341.","journal-title":"Dev Change"},{"issue":"8\u20139","key":"21712_CR33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/17441692.2021.1945123","volume":"16","author":"EM da Fonseca","year":"2021","unstructured":"da Fonseca EM, Nattrass N, Lazaro LLB, Bastos FI. Political discourse, denialism and leadership failure in Brazil\u2019s response to COVID-19. Glob Public Health. 2021;16(8\u20139):1251\u201366.","journal-title":"Glob Public Health"},{"issue":"7","key":"21712_CR34","doi-asserted-by":"crossref","first-page":"e00001022","DOI":"10.1590\/0102-311xen001022","volume":"38","author":"M Hentschke-Lopes","year":"2022","unstructured":"Hentschke-Lopes M, Botton MR, Borges P, Freitas M, Mancuso ACB, Matte U. Sales of COVID kit drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency. Cad Sa\u00fade P\u00fablica. 2022;38(7):e00001022.","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"21712_CR35","doi-asserted-by":"crossref","unstructured":"Lalwani P, Salgado BB, Filho IVP, da Silva DSS, de Morais TB do, Jord\u00e3o N et al. MF,. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study. Int J Infect Dis. 2021;110:141\u201350.","DOI":"10.1016\/j.ijid.2021.07.017"},{"key":"21712_CR36","unstructured":"Superior Electoral Court. Electoral Statistics. Portal do TSE. 2022. https:\/\/sig.tse.jus.br\/ords\/dwapr\/r\/seai\/sig-eleicao\/home. Accessed January 2024."},{"key":"21712_CR37","doi-asserted-by":"crossref","unstructured":"Xavier DR, Silva EL e, Lara FA, Silva GRR e, Oliveira MF, Gurgel H et al. Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study. Lancet Reg Health Am. 2022;10:100221.","DOI":"10.1016\/j.lana.2022.100221"},{"key":"21712_CR38","unstructured":"Henrique ALB. COVID-19 Vaccination in Brazil Is a Success, Despite the Failure of the Federal Government. O\u2019Neill Institute. 2022. https:\/\/oneill.law.georgetown.edu\/covid-19-vaccination-in-brazil-is-a-success-despite-the-failure-of-the-federal-government\/. Accessed December 2023."},{"key":"21712_CR39","unstructured":"Te\u00f3filo S, Lima B. Anvisa informa \u00e0 CPI que venda de \u2018kit covid\u2019 cresceu 166% em 2020. Correio Brasiliense. Pol\u00edtica. 2021. https:\/\/www.correiobraziliense.com.br\/politica\/2021\/06\/4933493-anvisa-informa-a-cpi-que-venda-de----kit-covid----cresceu-166--em-2020.html. Accessed October, 2023."},{"key":"21712_CR40","unstructured":"Rede Brasil Atual - RBA. Bolsonaro usou Amazonas para. experi\u00eancias de imunidade de rebanho e cloroquina, diz vice-governador. Rede Brasil Atual. 2021. https:\/\/www.redebrasilatual.com.br\/saude-e-ciencia\/bolsonaro-usou-amazonas-para-experiencias-de-imunidade-de-rebanho-e-cloroquina-diz-vice-governador\/. Accessed October, 2023."},{"issue":"18","key":"21712_CR41","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa2115869","volume":"386","author":"G Reis","year":"2022","unstructured":"Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, et al. Effect of early treatment with ivermectin among patients with Covid-19. N Engl J Med. 2022;386(18):1721\u201331.","journal-title":"N Engl J Med"},{"key":"21712_CR42","first-page":"100062","volume":"2","author":"PR Martins-Filho","year":"2021","unstructured":"Martins-Filho PR, Ferreira LC, Heimfarth L, Ara\u00fajo AADS, Quintans-J\u00fanior LJ. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. Lancet Reg Health Am. 2021;2:100062.","journal-title":"Lancet Reg Health Am"},{"key":"21712_CR43","doi-asserted-by":"crossref","first-page":"116055","DOI":"10.1016\/j.biopha.2023.116055","volume":"171","author":"A Pradelle","year":"2024","unstructured":"Pradelle A, Mainbourg S, Provencher S, Massy E, Grenet G, Lega JC. Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate. Biomed Pharmacother. 2024;171:116055.","journal-title":"Biomed Pharmacother"},{"key":"21712_CR44","doi-asserted-by":"crossref","unstructured":"Sott MK, Bender MS, da Silva Baum K. Covid-19 outbreak in Brazil: Health, Social, Political, and Economic implications. Int J Health Serv 2022;00207314221122658.","DOI":"10.1177\/00207314221122658"},{"key":"21712_CR45","unstructured":"Perez OC, Santana L. A\u00e7\u00f5es do Cons\u00f3rcio Nordeste no combate \u00e0 pandemia de Covid-19. NAU Social. 31 de outubro de 2020;11(21):259\u201370."},{"key":"21712_CR46","unstructured":"Pitta I, Brito J. Ex\u00e9rcito multiplicou produ\u00e7\u00e3o de cloroquina por 12 vezes em 2020. CNN Brasil. 2021. https:\/\/www.cnnbrasil.com.br\/politica\/exercito-multiplica-producao-de-cloroquina-por-12-vezes-em-2020\/. Accessed January, 2024."},{"key":"21712_CR47","unstructured":"Muniz B, Fonseca B. Farm\u00e1cias venderam mais de 52 milh\u00f5es de comprimidos do kit covid na pandemia. El Pa\u00eds Brasil. 2021. https:\/\/brasil.elpais.com\/brasil\/2021-04-21\/farmacias-venderam-mais-de-52-milhoes-de-comprimidos-do-kit-covid-na-pandemia.html. Accessed November 2023."},{"key":"21712_CR48","first-page":"100222","volume":"10","author":"A Bigoni","year":"2022","unstructured":"Bigoni A, Malik AM, Tasca R, Carrera MBM, Schiesari LMC, Gambardella DD, et al. Brazil\u2019s health system functionality amidst of the COVID-19 pandemic: an analysis of resilience. Lancet Reg Health Am. 2022;10:100222.","journal-title":"Lancet Reg Health Am"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21712-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:40:25Z","timestamp":1743756025000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21712-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21712"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21712-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Sergio Arouca National School of Public Health\/ Oswaldo Cruz Foundation (Technical Opinion No. 5.710.204) to access the database containing individually traceable but anonymized patient information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1250"}}